Abstract:Cadmium (Cd) is a common environmental pollutant and occupational toxicant that seriously affects various mammalian organs, especially the kidney. Iron ion is an essential trace element in the body, and the disorder of iron metabolism is involved in the development of multiple pathological processes. An iron overload can induce a new type of cell death, defined as ferroptosis. However, whether iron metabolism is abnormal in Cd-induced nephrotoxicity and the role of ferroptosis in Cd-induced nephrotoxicity need to be further elucidated. Sprague Dawley male rats were randomly assigned into three groups: a control group, a 50 mg/L CdCl2-treated group, and a 75 mg/L CdCl2-treated group by drinking water for 1 month and 6 months, respectively. The results showed that Cd could induce renal histopathological abnormalities and dysfunction, disrupt the mitochondria's ultrastructure, and increase the ROS and MDA content. Next, Cd exposure caused GSH/GPX4 axis blockade, increased FTH1 and COX2 expression, decreased ACSL4 expression, and significantly decreased the iron content in proximal tubular cells or kidney tissues. Further study showed that the expression of iron absorption-related genes SLC11A2, CUBN, LRP2, SLC39A14, and SLC39A8 decreased in proximal tubular cells or kidneys after Cd exposure, while TFRC and iron export-related gene SLC40A1 did not change significantly. Moreover, Cd exposure increased SLC11A2 gene expression and decreased SLC40A1 gene expression in the duodenum. Finally, NAC or Fer-1 partially alleviated Cd-induced proximal tubular cell damage, while DFO and Erastin further aggravated Cd-induced cell damage. In conclusion, our results indicated that Cd could cause iron deficiency and chronic kidney injury by interfering with the iron metabolism rather than typical ferroptosis. Our findings suggest that an abnormal iron metabolism may contribute to Cd-induced nephrotoxicity, providing a novel approach to preventing kidney disease in clinical practice.

N-acetylcysteine delayed cadmium-induced chronic kidney injury by activating the sirtuin 1-P53 signaling pathway

Sirtuin-1 attenuates cadmium-induced renal cell senescence through p53 deacetylation

N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation

N‐acetyl‐L‐cysteine Protects Against Cadmium‐induced Neuronal Apoptosis by Inhibiting ROS‐dependent Activation of Akt/mTOR Pathway in Mouse Brain

MiR-34a/Sirt1/p53 Signaling Pathway Contributes to Cadmium-Induced Nephrotoxicity: A Preclinical Study in Mice

SIRT1 alleviates Cd nephrotoxicity through NF-κB/p65 deacetylation–mediated pyroptosis in rat renal tubular epithelial cells

Mitochondrial GPX4 Acetylation is Involved in Cadmium-Induced Renal Cell Ferroptosis

Roles of Reactive Oxygen Species and Mitochondria in Cadmium-Induced Injury of Liver Cells.

Ameliorative effects of resveratrol against cadmium-induced nephrotoxicity <i>via</i> modulating nuclear xenobiotic receptor response and PINK1/Parkin-mediated Mitophagy

Persistent activation of Nrf2 promotes a vicious cycle of oxidative stress and autophagy inhibition in cadmium-induced kidney injury

Sirtuin-1 Ameliorates Cadmium-Induced Endoplasmic Reticulum Stress and Pyroptosis Through XBP-1s Deacetylation in Human Renal Tubular Epithelial Cells.

Resveratrol Rescues Cadmium-Induced Mitochondrial Injury by Enhancing Transcriptional Regulation of PGC-1α and SOD2 Via the Sirt3/FoxO3a Pathway in TCMK-1 Cells.

N-acetylcysteine protects against cadmium-induced germ cell apoptosis by inhibiting endoplasmic reticulum stress in testes

Cadmium Induces Kidney Iron Deficiency and Chronic Kidney Injury by Interfering with the Iron Metabolism in Rats

Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism

Nrf2 Deficiency Aggravates the Kidney Injury Induced by Subacute Cadmium Exposure in Mice

Nrf2 protects against renal fibrosis induced by chronic cadmium exposure in mice

Cadmium induces renal inflammation by activating the NLRP3 inflammasome through ROS/MAPK/NF-κB pathway in vitro and in vivo

N-methyl-d-aspartate receptor 1 activation mediates cadmium-induced epithelial-mesenchymal transition in proximal tubular cells

Attenuation of inflammation, oxidative stress and TGF-β1/Smad3 signaling and upregulation of Nrf2/HO-1 signaling mediate the protective effect of diallyl disulfide against cadmium nephrotoxicity

Activation of NLRP3 signaling contributes to cadmium-induced bone defects, associated with autophagic flux obstruction